Search alternatives:
significant binding » significant burden (Expand Search), significant benefits (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
binding decrease » binding database (Expand Search)
Showing 901 - 920 results of 13,211 for search '(( significant increase decrease ) OR ( significant binding decrease ))*', query time: 0.63s Refine Results
  1. 901
    S1 Data -

    S1 Data - by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 902
    Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.

    Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 903
    Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.

    Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 904
    Western blot analysis of drug combinations.

    Western blot analysis of drug combinations. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 905
    ALKL1196M –ABT199 interactions.

    ALKL1196M –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 906
    ALK<sup>wt</sup>–ABT199 interactions.

    ALK<sup>wt</sup>–ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 907
    BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression.

    BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 908
    BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>.

    BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 909
    Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment.

    Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 910
    Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log<sub>10</sub> drop and had a statistically significant loss of bacterial viability across both storage conditions. Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing. However, M:D FMT products exhibited the smallest median loss of bacterial viability following lyophilization and outperforms other lyopreservatives. Data is represented as median and range in parentheses. Significant p-values are bolded. Abbreviations: C, centrifuged; NC, not centrifuged; MD, maltodextrin and trehalose.

    Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the g... by Nina K. Randolph (21030732)

    Published 2025
    Save to List
    Saved in:
  11. 911
    Magnification x2 of Fig 1B.

    Magnification x2 of Fig 1B. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 912
    Variation of organic acids in feed after supplementation of FCM.

    Variation of organic acids in feed after supplementation of FCM. by Ruiming Xiao (6389546)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 913
    Regulation of NF-κB target genes mRNA levels in <i>L</i>. <i>intracellularis</i> infected PK-15 cells.

    Regulation of NF-κB target genes mRNA levels in <i>L</i>. <i>intracellularis</i> infected PK-15 cells. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 914
    Viability of <i>L</i>. <i>intracellularis</i>.

    Viability of <i>L</i>. <i>intracellularis</i>. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 915
    Fig 3 -

    Fig 3 - by Ruiming Xiao (6389546)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 916
    Reduced cell viability in Dkp23- and Vaccine-infected PK-15 cells.

    Reduced cell viability in Dkp23- and Vaccine-infected PK-15 cells. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 917
    Primers used for PCR and qRTPCR.

    Primers used for PCR and qRTPCR. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 918
    Western blots used for Fig 4C.

    Western blots used for Fig 4C. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 919
    Immunofluorescence staining of p65 NF-κB in Poly (I:C) treated and untreated PK-15 cells at 2, 8, 24 and 48 hours post treatment.

    Immunofluorescence staining of p65 NF-κB in Poly (I:C) treated and untreated PK-15 cells at 2, 8, 24 and 48 hours post treatment. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 920
    Fig 2 -

    Fig 2 - by Ruiming Xiao (6389546)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: